Home
Live Updates
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer : comparemela.com
Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
Starlight Therapeutics— a Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective...
Related Keywords
California ,
United States ,
San Francisco ,
Los Angeles ,
Pionyr Immunotherapeutics ,
Marc Chamberlain ,
Norris Cancer Center ,
Moores Cancer Center ,
Moffit Cancer Center ,
Starlight Therapeutics Inc ,
University Of Washington ,
Securities Exchange ,
University Of California ,
Columbia University College Of Physicians ,
Fred Hutchinson Cancer Center ,
Exchange Commission On ,
University Of South Florida ,
Starlight Therapeutics ,
Lantern Pharma ,
Chief Medical ,
Lantern Logos ,
South Florida ,
Cascadian Therapeutics ,
Seattle Genetics ,
Panna Sharma ,
Columbia University College ,
Securities Act ,
Securities Exchange Act ,
Risk Factors ,
Annual Report ,
Exchange Commission ,
Markets ,
comparemela.com © 2020. All Rights Reserved.